228
Views
1
CrossRef citations to date
0
Altmetric
CASE SERIES

Nasopharyngeal Mycobacterium abscessus Infection: A Case Report and Literature Review

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, & show all
Pages 3955-3963 | Received 03 Apr 2023, Accepted 02 Jun 2023, Published online: 20 Jun 2023

References

  • Matsumoto Y, Kinjo T, Motooka D, et al. Comprehensive subspecies identification of 175 nontuberculous mycobacteria species based on 7547 genomic profiles. Emerg Microbes Infect. 2019;8(1):1043–1053. doi:10.1080/22221751.2019.1637702
  • Namkoong H, Kurashima A, Morimoto K, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22(6):1116–1117. doi:10.3201/eid2206.151086
  • Honda JR, Alper S, Bai X, Chan ED. Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections. Curr Opin Immunol. 2018;54:66–73. doi:10.1016/j.coi.2018.06.001
  • Henkle E, Hedberg K, Schafer SD, Winthrop KL. Surveillance of extrapulmonary nontuberculous mycobacteria infections, Oregon, USA, 2007–2012. Emerg Infect Dis. 2017;23(10):1627–1630. doi:10.3201/eid2310.170845
  • Lee MR, Sheng WH, Hung CC, Yu CJ, Lee LN, Hsueh PR. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21(9):1638–1646. doi:10.3201/2109.141634
  • Jeong SH, Kim SY, Huh HJ, et al. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. Int J Infect Dis. 2017;60:49–56. doi:10.1016/j.ijid.2017.05.007
  • Asami T, Aono A, Chikamatsu K, et al. Efficacy estimation of a combination of triple antimicrobial agents against clinical isolates of Mycobacterium abscessus subsp. abscessus in vitro. JAC Antimicrob Resist. 2021;3(1):dlab004. doi:10.1093/jacamr/dlab004
  • Johansen MD, Herrmann JL, Kremer L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat Rev Microbiol. 2020;18(7):392–407. doi:10.1038/s41579-020-0331-1
  • Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
  • Nabi S, Marglani OA, Javer AR. Mycobacterium Avium-intracellulare Sinusitis. J Otolaryngol Head Neck Surg. 2010;39(5):E51–E55.
  • Hicks MD, Karempelis PS, Janus SC. Mycobacterium chelonae sinusitis in an immunocompetent adult. JAMA Otolaryngol Head Neck Surg. 2016;142(8):805–806. doi:10.1001/jamaoto.2016.1865
  • Oki Y, Hatakeyama H, Komatsu M, et al. A first case report of nasopharyngeal Mycobacterium abscessus subspecies massiliense infection. Eur J Med Res. 2021;26(1):109. doi:10.1186/s40001-021-00578-8
  • Hussin N, Mat Baki M, Sani A. Chronic large non healing ulcer: non-tuberculous mycobacterial infection of the laryngopharynx. Korean J Fam Med. 2017;38(5):303–306. doi:10.4082/kjfm.2017.38.5.303
  • Mullin D, Jothi S, Healy D. Mycobacterium chelonae infections involving the head and neck. Ann Otol Rhinol Laryngol. 2009;118(10):714–720. doi:10.1177/000348940911801006
  • Lehman B, Procop GW, Silva Merea V, Harrington SM, Mawhorter SD, Benninger MS. Chronic laryngitis caused by Mycobacterium kansasii in a traveler. Laryngoscope. 2019;129(11):2534–2536. doi:10.1002/lary.27952
  • McEwan JA, Mohsen AH, Schmid ML, McKendrick MW. A hoarse voice: atypical mycobacterial infection of the larynx. J Laryngol Otol. 2001;115(11):920–922. doi:10.1258/0022215011909369
  • Yan K, Taxy JB, Paintal A, Friedman AD. Atypical laryngeal infections: localized lesions from unusual organisms may simulate malignancy. Ann Otol Rhinol Laryngol. 2020;129(1):82–86. doi:10.1177/0003489419875755
  • Al-Zahid S, Wright T, Reece P. Laryngeal Inflammatory Pseudotumour Secondary to Mycobacterium kansasii. Case Rep Pathol. 2018;2018:9356243. doi:10.1155/2018/9356243
  • Wang BY, Amolat MJ, Woo P, Brandwein-Gensler M. Atypical mycobacteriosis of the larynx: an unusual clinical presentation secondary to steroids inhalation. Ann Diagn Pathol. 2008;12(6):426–429. doi:10.1016/j.anndiagpath.2007.04.011
  • Bryant JM, Grogono DM, Rodriguez-Rincon D, et al. Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium. Science. 2016;354(6313):751–757. doi:10.1126/science.aaf8156
  • Yoshida M, Chien JY, Morimoto K, et al. Molecular epidemiological characteristics of Mycobacterium abscessus complex derived from non-cystic fibrosis patients in Japan and Taiwan. Microbiol Spectr. 2022;10(3):e0057122. doi:10.1128/spectrum.00571-22
  • Boeck L, Burbaud S, Skwark M, et al. Mycobacterium abscessus pathogenesis identified by phenogenomic analyses. Nat Microbiol. 2022;7(9):1431–1441. doi:10.1038/s41564-022-01204-x
  • Lipworth S, Hough N, Leach L, et al. Whole-genome sequencing for predicting clarithromycin resistance in Mycobacterium abscessus. Antimicrob Agents Chemother. 2019;63(1):e01204–e01218.
  • Lipworth S, Hough N, Buchanan R, et al. Improved performance predicting clarithromycin resistance in Mycobacterium abscessus on an independent data set. Antimicrob Agents Chemother. 2019;63(8):e00400–e00419.
  • Nash KA, Brown-Elliott BA, Wallace RJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367–1376. doi:10.1128/AAC.01275-08
  • Brown-Elliott BA, Vasireddy S, Vasireddy R, et al. Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs. J Clin Microbiol. 2015;53(4):1211–1215. doi:10.1128/JCM.02950-14
  • Kwak N, Dalcolmo MP, Daley CL, et al. Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis. Eur Respir J. 2019;54(1):1801991. doi:10.1183/13993003.01991-2018